Glenmark Life Sciences Ltd. (ALIVUS) Share Price Hits Fresh 52-Week High

Glenmark Life Sciences Ltd. Share Price rose 2.74% to Rs 1,364.65 and touched a fresh 52-week high of Rs 1,385.45. Market capitalisation stood at Rs 16,307.73 crore.

Glenmark Life Sciences Ltd. Share Price is at Rs 1,364.65, up 2.74% from the previous close of Rs 1,328.30, after the stock touched a fresh 52-week high of Rs 1,385.45. With market capitalisation at Rs 16,307.73 crore, the move has brought Glenmark Life Sciences Ltd. Share Price firmly into today’s stock market conversation.

The verified data confirms a clear price event: the stock opened at Rs 1,353.50, traded between Rs 1,343.10 and Rs 1,385.45, and recorded turnover of Rs 1.83 crore on volume of 13,380 shares. That combination places the counter among notable market movers in today’s Indian stock market session, even though the supplied data does not establish a company-specific catalyst behind the move.

For investors tracking Glenmark Life Sciences Ltd. Share Price Today, the key takeaway is that the stock has reached a one-year high while still holding most of the day’s gains. In Univest’s view, that makes the stock relevant not only from a price action perspective, but also from a valuation and sector-comparison angle. The next step is to examine what today’s move says about Glenmark Life Sciences Ltd. Stock News, the company’s market positioning and how its core financial ratios compare with the broader Healthcare universe.

Glenmark Life Sciences Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,364.65
Previous Close	Rs 1,328.3
Today's Change	+Rs 36.35 (+2.74%)
Day Open	Rs 1,353.5
Fresh 52-Week High	Rs 1,385.45
Day Low	Rs 1,343.1
Current Volume	13,380
Turnover	Rs 1.83 crore
Market Capitalisation	Rs 16,307.73 crore

Glenmark Life Sciences Ltd. (ALIVUS) traded at Rs 1,364.65. versus the previous close of Rs 1,328.3, a rise of 2.74%. The stock opened at Rs 1,353.5, reached Rs 1,385.45, touched Rs 1,343.1. Reported volume was 13,380.

Glenmark Life Sciences Ltd. Share Price Today reflects a strong session, with the stock rising from the previous close of Rs 1,328.30 to Rs 1,364.65 and touching a fresh 52-week peak of Rs 1,385.45. The intraday range of Rs 1,343.10 to Rs 1,385.45 shows sustained buying interest through the morning trade rather than a marginal uptick.

From the opening level of Rs 1,353.50, the stock moved higher and tested its yearly high during the session. The absolute day gain stood at Rs 36.35, translating into a 2.74% rise. That is a meaningful single-session move for investors searching for Glenmark Life Sciences Ltd. Share Price Update, especially when it coincides with a fresh one-year high.

Turnover was Rs 1.83 crore and current volume stood at 13,380 shares. Even without a supplied historical average volume benchmark, today’s traded value confirms active participation as the stock approached its 52-week peak. For readers following Glenmark Life Sciences Ltd. Share Price Live and broader Stock Updates, the important fact is that the stock not only made a new high but also remained close to that zone, which keeps the price action in focus.

Because this article is based only on verified screener data, the move can be described with confidence as a fresh 52-week high event. What needs deeper examination is whether Glenmark Life Sciences Ltd. Fundamental Analysis and relative valuation support this attention.

Glenmark Life Sciences Ltd. (ALIVUS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 16,307.73 crore
P/E Ratio	31.12x
P/B Ratio	0.45x
ROE	-2.89%
ROCE	-0.26%

Glenmark Life Sciences Ltd. was valued at a P/E ratio of 31.12x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	31.12x
Benchmark Median P/E	21.04x
Benchmark Average P/E	71.82x
Benchmark P/E Range	0x to 3,417.8x
Company P/B Ratio	0.45x
Benchmark Median P/B	1.89x
Company ROE	-2.89%
Benchmark Median ROE	10.7%
Company ROCE	-0.26%
Benchmark Median ROCE	13.16%
Company Market Capitalisation	Rs 16,307.73 crore
Benchmark Median Market Cap	Rs 130.8 crore

Glenmark Life Sciences Ltd. (ALIVUS) is classified under sector: Healthcare.

Glenmark Life Sciences Ltd. (ALIVUS) has a P/E ratio of 31.12x, which is above the benchmark median of 21.04x, a difference of +47.91%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Glenmark Life Sciences Ltd. (ALIVUS) has a ROE of -2.89%, which is below the benchmark median of 10.7%, a difference of -127.01%. Glenmark Life Sciences Ltd. (ALIVUS) has a ROCE of -0.26%, which is below the benchmark median of 13.16%, a difference of -101.98%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	3,032.97	31.12	0.45	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,707.2	40.2	8.18	28.21	26.35
Beta Drugs Ltd.	BETA	2,631.45	63.43	6.27	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,537.93	33.3	6.87	-2.6	16.92
Sai Parenteral's Ltd.	SAIPARENT	2,513.58	176.28	3.26	13.9	12.97

Glenmark Life Sciences Ltd. (ALIVUS) has a P/E ratio of 31.12x compared with the displayed peer median of 40.2x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Glenmark Life Sciences Ltd. (ALIVUS) has a market capitalisation of Rs 16,307.73 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Glenmark Life Sciences Ltd.

Glenmark Life Sciences Ltd. Stock News is attracting attention because several verified factors are lining up at once:

• Fresh price event: the stock touched a new 52-week high of Rs 1,385.45 and was trading at Rs 1,364.65, up 2.74% on the day.
• Meaningful intraday move: the price range of Rs 1,343.10 to Rs 1,385.45 and turnover of Rs 1.83 crore confirm active session participation.
• Large market size: market capitalisation of Rs 16,307.73 crore is much larger than the supplied sector benchmark median and peer market caps.
• Mixed valuation profile: P/E of 31.12 is above the sector median of 21.04, while P/B of 0.45 is below the sector median of 1.89.
• Profitability watchpoint: ROE of -2.89 and ROCE of -0.26 remain below sector and most peer benchmarks.

About Glenmark Life Sciences Ltd.

Glenmark Life Sciences Ltd. (ALIVUS) is being tracked here as a listed Healthcare company within Univest’s stock coverage universe. In the current verified dataset, the company is identified by its listed name, trading symbol, sector classification and live market metrics such as Share Price, market capitalisation and valuation ratios.

For readers following Glenmark Life Sciences Ltd. Latest News and Glenmark Life Sciences Ltd. Company News, the present article is focused on the stock’s fresh 52-week high event rather than a business-profile update. The supplied data establishes its Healthcare sector classification, current market value of Rs 16,307.73 crore and the financial ratios used in this stock analysis. That makes the company relevant in today’s Market News flow because the stock has entered a fresh yearly high zone while also presenting a mixed valuation and profitability profile.

Track Glenmark Life Sciences Ltd. Share Price on Univest

Use Glenmark Life Sciences Ltd. (ALIVUS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

On Univest, investors can track Glenmark Life Sciences Ltd. Share Price through live price moves, 52-week levels, valuation ratios and broader market insights. That helps users follow Glenmark Life Sciences Ltd. Share Price Today in one place as part of regular Stock Market Today monitoring.

Univest also helps users compare Glenmark Life Sciences Ltd. Share Price with peer metrics, sector benchmarks and key financial ratios such as P/E, P/B, ROE and ROCE. For anyone watching Breakout Stocks, Momentum Stocks or daily Share Market Today trends, that context matters because a fresh one-year high can attract attention for very different reasons across different companies.

As today’s Glenmark Life Sciences Ltd. Share Price Update shows, the headline event is clear: a fresh 52-week peak. What investors may want to monitor next on Univest is whether the stock sustains activity near this zone and how its relative valuation and profitability profile evolve versus peers and the wider Healthcare benchmark.

Frequently Asked Questions

What is the current Glenmark Life Sciences Ltd. Share Price?

Ans. Glenmark Life Sciences Ltd. Share Price was Rs 1,364.65 at the time of this update. The stock was up 2.74% from the previous close of Rs 1,328.30, keeping it in focus during today’s market session.

Why is Glenmark Life Sciences Ltd. Share Price in focus today?

Ans. The stock is in focus because it touched a fresh 52-week high of Rs 1,385.45. Glenmark Life Sciences Ltd. Share Price also showed a day gain of Rs 36.35, highlighting notable price action in today’s trade.

What was the fresh 52-week high for Glenmark Life Sciences Ltd.?

Ans. Glenmark Life Sciences Ltd. reached a fresh 52-week high of Rs 1,385.45. The stock later traded at Rs 1,364.65, which still kept it close to the day’s peak and preserved most of the session’s gains.

How much did Glenmark Life Sciences Ltd. Share Price rise today?

Ans. Glenmark Life Sciences Ltd. Share Price rose by Rs 36.35 on the session, a gain of 2.74%. The move came from a previous close of Rs 1,328.30 and followed an opening price of Rs 1,353.50.

What do today’s trading levels show for the stock?

Ans. Today’s trading range ran from Rs 1,343.10 to Rs 1,385.45. That indicates the stock stayed firm through the session, with Glenmark Life Sciences Ltd. Share Price spending the day near its fresh one-year high zone.

What is the market capitalisation of Glenmark Life Sciences Ltd.?

Ans. Glenmark Life Sciences Ltd. had a market capitalisation of Rs 16,307.73 crore in the supplied data. That is far above the Healthcare sector benchmark median market cap of Rs 130.80 crore shown in this comparison.

How is the stock valued on P/E and P/B ratios?

Ans. The stock trades at a P/E ratio of 31.12 and a P/B ratio of 0.45. Its P/E is above the sector median of 21.04, while its P/B is below the sector median of 1.89.

What do ROE and ROCE indicate for Glenmark Life Sciences Ltd.?

Ans. The supplied profitability ratios show ROE at -2.89 and ROCE at -0.26. Both are below the Healthcare sector medians of 10.70 for ROE and 13.16 for ROCE in the benchmark snapshot.

How does Glenmark Life Sciences Ltd. compare with peers?

Ans. Glenmark Life Sciences Ltd. stands out for size, with market capitalisation of Rs 16,307.73 crore versus the supplied peers at roughly Rs 2,513.58 crore to Rs 3,032.97 crore. Its P/B is lower, while profitability is weaker than most peers.

What should investors monitor next in Glenmark Life Sciences Ltd. Stock News?

Ans. Investors may watch whether Glenmark Life Sciences Ltd. Share Price sustains activity near its fresh 52-week high, while also tracking how its P/E, P/B, ROE and ROCE compare with peers and the wider Healthcare sector.